Protagonist Therapeutics, Inc. Share Price
Equities
PTGX
US74366E1029
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.15 USD | +1.99% | -1.80% | +9.68% |
Sales 2024 * | 208M 16.61B | Sales 2025 * | 120M 9.59B | Capitalization | 1.47B 118B |
---|---|---|---|---|---|
Net income 2024 * | 44M 3.52B | Net income 2025 * | -6M -480M | EV / Sales 2024 * | 5.24 x |
Net cash position 2024 * | 388M 31.03B | Net cash position 2025 * | 637M 51.03B | EV / Sales 2025 * | 6.99 x |
P/E ratio 2024 * |
35.1
x | P/E ratio 2025 * |
-31.1
x | Employees | 112 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.53% |
Latest transcript on Protagonist Therapeutics, Inc.
1 day | +1.99% | ||
1 week | -1.80% | ||
Current month | -13.07% | ||
1 month | -11.69% | ||
3 months | +0.88% | ||
6 months | +78.62% | ||
Current year | +9.68% |
Managers | Title | Age | Since |
---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 67 | 30/11/08 |
Asif Ali
DFI | Director of Finance/CFO | 50 | 17/04/22 |
Chief Tech/Sci/R&D Officer | - | 30/06/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lewis Williams
BRD | Director/Board Member | 74 | 07/06/17 |
Harold Selick
CHM | Chairman | 69 | 31/01/09 |
Daniel Swisher
BRD | Director/Board Member | 61 | 25/10/23 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 2 M€ | -.--% | ||
0.05% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 25.15 | +1.99% | 461,248 |
25/04/24 | 24.66 | -4.05% | 606,308 |
24/04/24 | 25.7 | -4.28% | 326,485 |
23/04/24 | 26.85 | +0.90% | 339,333 |
22/04/24 | 26.61 | +3.90% | 296,277 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.68% | 1.47B | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- PTGX Stock